Events

RSA Inspiring Leaders Webinar w/ Jackie Hunter

In this webinar, participants will hear from four distinguished industry leaders with inspiring stories.

They will share insights on the experiences, people and decisions that shaped their successful careers, talking about what constitutes great leadership and how that contributes to innovative, breakthrough science.

Speakers
  • Jo Pisani, Non-Executive Director, The RSA Group
  • Dr. Niven R Narain, Co-founder, President & CEO, BERG
  • Prof. Jackie Hunter, Board Director BenevolentAI
  • Shiva Dustdar, Head of Division, Innovation Finance Advisory for the European Investment Bank
Who Should Attend?

Senior professionals who are:

  • Aspiring and existing leaders from any sector or background
  • Life science executives searching for leadership advice
  • Women in leadership looking for guidance and role models
  • C-suite professionals
What You Will Learn

In this webinar, participants will gain:

  • Advice from the experts on what good, effective, inclusive leadership means
  • How to achieve this leadership and the mindset needed to lead well
  • Insights on building resilience, facing adversity, embracing your differences and being confident
  • An understanding of why diversity is vital to success
  • Advice that leaders from any industry sector would gain incredible value from
Register here →


Jackie Hunter

Board Director of BenevolentAI

Jackie Hunter is a Board Director of BenevolentAI.  Jackie has over thirty years of experience in the bioscience research sector, working across academia and industry including leading neurology and gastrointestinal drug discovery and early clinical development for GlaxoSmithKline. She founded OI Pharma Partners in 2010 to support the life science sector in harnessing the power of open innovation and most recently was Chief Executive of the Biotechnology and Biological Sciences Research Council. She holds a personal chair from St George's Hospital Medical School, which was awarded in recognition of her contribution to bioscience research. In 2010 she was awarded a CBE in the Queen's Birthday Honours list for Services to the Pharmaceutical Industry.

More Posts

You Might Also Like

News
BenevolentAI achieves further milestones in AI-enabled target identification collaboration with AstraZeneca
Two additional AI-generated novel targets selected by AstraZeneca for its drug development portfolio, resulting in two milestone payments for BenevolentAI.
Oct 6, 2022
News
Interim results for the six months ended 30 June 2022
Continued operational progress and strengthened financial position provides capital for key value inflection points and continued investment in leading technology platform.
Sep 27, 2022
News
Analyst / Investor Event
BenevolentAI announces that during its analyst / investor event and interim results presentation being held in London today, new information on the Company’s BEN-2293 Phase Ib study results will be disclosed.
Sep 27, 2022
Blog
Building the data foundations to accelerate drug discovery
Mark Davies, BenevolentAI’s SVP Informatics and Data, discusses innovations that enable BenevolentAI to leverage biomedical data in drug discovery.
Sep 22, 2022
News
Analyst / Investor Event and Interim Results
BenevolentAI is pleased to announce the full agenda for its upcoming analyst/investor event and interim results being held in London between 14:00 – 17:00 BST (09:00 – 12:00 ET) on Tuesday, 27 September 2022.
Sep 16, 2022
Video
Text & Data Mining in Drug Discovery: A Conversation with Springer Nature
Hear Mark Davies, SVP Informatics and Data, speak to Springer Nature about how BenevolentAI is leveraging the scientific literature to expedite drug discovery.
Sep 2, 2022